Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG639025 Inhibitors

EG639025 inhibitors are a class of chemical compounds characterized by their ability to inhibit a specific molecular target associated with the modulation of cellular signaling pathways. These inhibitors often possess unique structural motifs that enable high specificity and potency in binding to their target, typically a protein or enzyme involved in key regulatory functions within the cell. By interacting with their target's active or allosteric sites, EG639025 inhibitors can alter the normal function of the protein, either blocking its enzymatic activity or preventing protein-protein interactions critical to downstream signaling events. The molecular scaffold of these inhibitors is often designed to enhance selectivity and binding affinity, which can involve optimizing hydrophobic interactions, hydrogen bonding, and electrostatic complementarity between the inhibitor and the target site. This specificity is vital for their function as it allows for minimal off-target effects and a clearer understanding of their molecular mechanisms within biochemical pathways.

The structural design of EG639025 inhibitors typically includes a core chemical framework that is modified to enhance cell permeability, metabolic stability, and binding characteristics. These modifications can include the addition of functional groups to increase solubility, improve cellular uptake, or reduce metabolic degradation. Additionally, the physicochemical properties of these inhibitors, such as their molecular weight, polar surface area, and lipophilicity, are carefully balanced to optimize their ability to effectively reach and interact with their intended molecular targets. The study of these inhibitors provides valuable insights into the regulation of cellular signaling and can serve as critical tools for elucidating the biological roles of the targeted pathways in various cellular contexts. This understanding is particularly important in the study of cellular processes such as signal transduction, proliferation, and apoptosis, allowing for a deeper exploration of the biochemical and structural basis of protein function and interaction networks.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flutamide

13311-84-7sc-204757
sc-204757A
sc-204757D
sc-204757B
sc-204757C
1 g
5 g
25 g
500 g
1 kg
$47.00
$156.00
$171.00
$525.00
$941.00
4
(1)

An antiandrogen that can modulate androgen receptor activity, potentially affecting Pate12 regulation.

Finasteride

98319-26-7sc-203954
50 mg
$105.00
3
(1)

A 5-alpha reductase inhibitor that can decrease dihydrotestosterone levels, possibly affecting Pate12 expression.

Bicalutamide

90357-06-5sc-202976
sc-202976A
100 mg
500 mg
$42.00
$146.00
27
(1)

Another antiandrogen that can alter androgen receptor signaling, potentially affecting Pate12 activity.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

An antifungal that can inhibit steroid synthesis, potentially affecting hormone-regulated proteins like Pate12.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

A more potent antiandrogen that can affect androgen receptor activity and potentially Pate12 expression.

Apalutamide

956104-40-8sc-507442
5 mg
$290.00
(0)

An androgen receptor antagonist that can disrupt androgen signaling, potentially influencing Pate12.

Spironolactone

52-01-7sc-204294
50 mg
$109.00
3
(1)

A steroid that acts as an androgen antagonist, which can modulate Pate12 through hormonal pathways.

Dutasteride

164656-23-9sc-207600
10 mg
$167.00
2
(1)

A dual 5-alpha reductase inhibitor, which can lead to reduced dihydrotestosterone and potentially affect Pate12 expression.

Abiraterone Acetate

154229-18-2sc-207240
5 mg
$231.00
1
(1)

An inhibitor of androgen biosynthesis that may impact Pate12 expression by reducing androgen levels.

Letrozole

112809-51-5sc-204791
sc-204791A
25 mg
50 mg
$87.00
$147.00
5
(1)

An aromatase inhibitor that can lower estrogen levels, indirectly affecting Pate12 if it is regulated by estrogen.